Mersana Therapeutics shares owned by MetLife Investment Advisors
Quarter-by-quarter ownership of Mersana Therapeutics (MRSN) shares owned by MetLife Investment Advisors
from 13F filings
Historical chart of MetLife Investment Advisors investment in Mersana Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Mersana Therapeutics held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Mersana Therapeutics by MetLife Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $108k | 47k | 2.32 |
| 2023-09-30 | $59k | 47k | 1.27 |
| 2023-06-30 | $154k | 47k | 3.29 |
| 2023-03-31 | $192k | 47k | 4.11 |
| 2022-12-31 | $273k | 47k | 5.86 |
| 2022-09-30 | $315k | 47k | 6.76 |
| 2022-06-30 | $178k | 39k | 4.62 |
| 2022-03-31 | $100k | 25k | 4.00 |
| 2021-12-31 | $168k | 27k | 6.22 |
| 2021-09-30 | $164k | 17k | 9.43 |
| 2021-06-30 | $351k | 26k | 13.58 |
| 2021-03-31 | $342k | 21k | 16.18 |
| 2020-12-31 | $610k | 23k | 26.62 |
| 2020-09-30 | $427k | 23k | 18.63 |
| 2020-06-30 | $486k | 21k | 23.39 |
| 2020-03-31 | $107k | 18k | 5.83 |
More positions owned by MetLife Investment Advisors
View all positions for MetLife Investment Advisors